Skip to main content Back to Top
Advertisement

7/10/2019

Mineral Oil and Petrolatum Ophthalmic Ointment

Products Affected - Description

    • Artificial Tears, Rugby Laboratories, 15%/83%, 3.5 g NDC 00536-1086-91 - discontinued
    • Genteal PM Ointment, Alcon Labs, 15%/85%, 3.5 g Product 00078-0473-97
    • Lubrifresh PM, Major, 15%/83%, 3.5 g NDC 00904-6488-38
    • Puralube, Perrigo, 15%/85%, 1 g 20 count, NDC 00574-4025-20 - discontinued
    • Puralube, Perrigo, 15%/85%, 3.5 g NDC 00574-4025-35 - discontinued
    • Refresh Lacri-Lube, Allergan, 42.5%/56.8%, 3.5 g NDC 00023-0312-04
    • Refresh Lacri-Lube PM, Allergan, 42.5%/56.8%, 7 g NDC 00023-0312-07
    • Systane Nighttime Ointment, Alcon Labs, 3%/94%, 3.5 g Product 00065-0509-35

Reason for the Shortage

    • Allergan states the shortage is due to production delays.
    • Bausch Health has Soothe Night Time ointment available.
    • Major did not provide a reason for the shortage.
    • Alcon states the shortage is due to manufacturing issues.
    • Perrigo discontinued Puralube ointment products in early-2019.
    • Rugby discontinued Artificial Tears 3.5 gram tubes in January 2019.

Available Products

    • Refresh PM, Allergan, 42.5%/57.3%, 3.5 g NDC 00023-0240-04
    • Soothe Night Time, Bausch Health, 20%/80%, 3.5 g NDC 10119-0223-99

Estimated Resupply Dates

    • Alcon has Systane Nighttime ointment and Genteal PM ointment on back order and the company estimates a release date in late-July 2019.
    • Allergan has Lacri-Lube SOP ointment 3.5 gram, and Lacri-Lube SOP ointment 7 gram tubes on back order and the company estimates a release date in late-July 2019.
    • Major has Lubrifresh PM 3.5 gram tubes on back order and the company estimates a release date of October 2019.

Updated

Updated July 10, 2019 by Megan Dryer, PharmD. Created June 6, 2018 by Anthony Trovato, PharmD, BCPS. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins